Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Finished Goods (2023 - 2025)

Profound Medical (PROF) has 3 years of Finished Goods data on record, last reported at $5.3 million in Q4 2025.

  • For Q4 2025, Finished Goods rose 37.61% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, up 37.61%, while the annual FY2025 figure was $5.3 million, 37.61% up from the prior year.
  • Finished Goods reached $5.3 million in Q4 2025 per PROF's latest filing, down from $5.8 million in the prior quarter.
  • Across five years, Finished Goods topped out at $5.8 million in Q3 2025 and bottomed at $3.8 million in Q4 2024.
  • Average Finished Goods over 3 years is $5.0 million, with a median of $5.0 million recorded in 2023.
  • Peak YoY movement for Finished Goods: fell 17.27% in 2024, then surged 37.61% in 2025.
  • A 3-year view of Finished Goods shows it stood at $4.6 million in 2023, then dropped by 17.27% to $3.8 million in 2024, then soared by 37.61% to $5.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $5.3 million in Q4 2025, $5.8 million in Q3 2025, and $5.6 million in Q2 2025.